FS-laer assisted intrastomal arcuate keratotomy a success

Article

Intrastromal arcuate keratotomy performed with a femtosecond (FS) laser has an excellent safety profile, rapid recovery and stability of vision, claims a new paper.

Intrastromal arcuate keratotomy performed with a femtosecond (FS) laser has an excellent safety profile, rapid recovery and stability of vision, claims a new paper.

Dr Theresa Ruckel et al., Department of Ophthalmology, Paracelsus Medical University, Salzburg, Austria, conducted an interventional case series on 16 patients with corneal astigmatism. All patients were treated with an FS laser for paired arcuate cuts on the steep axis completely placed within the corneal stroma.

Patients were followed for six postoperative months. Preoperative and postoperative assessments included corrected and uncorrected visual acuities, manifest refraction, corneal topography, endothelial cell count, and corneal pachymetry. All patients answered a subjective questionnaire to evaluate patient satisfaction.

There were no perforations and all incisions were positioned at the planned locations. Mean refractive cylinder, after six months of follow-up, was reduced significantly from 1.41 D ± 0.66 to 0.33 ± 0.42 D.

Mean topographic astigmatism was reduced significantly from 1.50 ± 0.47 D preoperatively to 0.63 ± 0.34 D at the six months follow-up. The questionnaire results revealed that patient satisfaction was very high.

The FS laser is able to successfully treat corneal astigmatism without the risks linked to incisions that penetrate the Bowman membrane.

Please visit the latest online issue of the Journal of Cataract and Refractive Surgery to read the abstract.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.